Experience

Tay Therapeutics Ltd

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• CEO and Founder

  • Dec 2022 - Present

• CSO and Founder

  • Jan 2020 - Dec 2022



University of Dundee

• United Kingdom
• Research Services
• 700 & Above Employee

• Independent Investigator

  • Jan 2019 - Aug 2020

  I led the pre-incorporation work on a University of Dundee spin out company that discovers new drugs to treat skin disease and benefit from 7 years work in the University of Dundee that has led to the discovery of exciting compounds on our lead projects.Early successes include a first in class topical therapy for childhood eczema, skin cancer and a number of other serious skin conditions. We then initiated a new oral drug discovery project for the treatment of inflammatory diseases.

• Portfolio Manager for Innovative Targets, The Drug Discovery Unit

  • Nov 2011 - Jan 2019

  I manage the Innovative Targets Portfolio (ITP) activities in the DDU, with the aim of de-risking new areas of biology through the application of multi-disciplinary drug discovery.In May 2012 I was appointed to the academic post of Independent Investigator at the University of Dundee.

• Team Leader, Medicinal chemistry

  • Nov 2009 - Nov 2011

  Management of a team of Medicinal Chemists across multiple novel drug targets.



University of Dundee

• United Kingdom
• Research Services
• 700 & Above Employee

• Senior Medicinal chemist

  • 2007 - 2009

  As a Senior Medicinal Chemist I was the project leader for a number of hit to lead and lead optimisation projects using target based and phenotypic drug discovery approaches. As a Senior Medicinal Chemist I was the project leader for a number of hit to lead and lead optimisation projects using target based and phenotypic drug discovery approaches.



BioFocus

• Cambridge, United Kingdom

• Senior Scientist

  • Apr 2002 - Jan 2007

  A Medicinal Chemist working on the development of kinase inhibitors and on the design and synthesis of targeted libraries. Key achievements were the development of kinase fragment libraries and a groundbreaking DFG-out targeted kinase inhibitor library. A Medicinal Chemist working on the development of kinase inhibitors and on the design and synthesis of targeted libraries. Key achievements were the development of kinase fragment libraries and a groundbreaking DFG-out targeted kinase inhibitor library.